ABOUT
Children’s Rare Disease Network is a program of R.A.R.E. Project, a non-profit 501c3. R.A.R.E’s leadership is committed to ensuring that its programs support its mission, are relevant and impactful. R.A.R.E. exists to:
- Raise Rare Disease Awareness and Education
- Unify and Empower a vibrant rare disease community
- Fund innovations that support in-their-lifetime rare disease research
Team R.A.R.E.
- Nicole Boice – President & Founder
nicoleb@rareproject.org - Dean Suhr – COO & Director of Community Development
deans@rareproject.org - Jason Omenn – Director, Business Development
jasono@rareproject.org - Amy Grover – Director, Community Development
amyg@rareproject.org - Jen Engleman – Community Development Manager
jen@rareproject.org - Christie Draper – Community Development Manager
christied@rareproject.org - Lisa James – Community Development Manager
lisaj@rareproject.org - Ed Winkelmann – Corporate Engagement Advisor
edwinkelmann@eteventures.com
Board of Directors
- Bruce Crair – Former COO, Local.com
- John Crowley – CEO, Amicus Therapeutics
- Jesse Dylan – Founder, Wondros
- Hugh Hempel – Parent Advocate/Technology Exec.
- Caroline Loewy – Parent Advocate, Former CFO of Corcept Therapeutics
- Peter Pellizzon – Founder, Hollencrest Capital, Philanthropist
- Allison Young – Esq.
Advisory Board: Science
- Beth Ann Baber – PhD, CEO, Nicholas Conor Institute for Pediatric Cancer Research
- Ian Eslick – PhD, MIT Media Lab
- Emil Kakkis – PhD, CEO, Ultragenyx
- Jimmy Lin – PhD, MD Candidate, MHS, Johns Hopkins Bloomberg School of Public Health
- Christina Waters – PhD, Phillip Morris
- John Wilbanks – VP of Science, Creative Commons
Advisory Board: Advocacy
- John Ditton – COO, Kakkis Everylife Foundation
- Audrey Gordon – Executive Director, Progeria Research Foundation
- Chris Hempel – Founder, Addi and Cassi Fund
- Elizabeth Joshi – Joubert Syndrome Foundation
- Brad Margus – CEO, Envoy Therapeutics
- Lisa Moreno-Dickinson – CEO, StopCAIDNow
- Sue Kahn – National Tay-Sachs & Allied Diseases Association



